Germantown-based Cambridge Major Laboratories Inc., a global leader in pharmaceutical API development and manufacturing, and AAIPharma Services Corp. have announced the appointments of Ted Dolan as vice president of API operations and Syed Husain as vice president of the API business unit.
“Mr. Dolan’s experience operating and managing teams in the chemical and pharmaceutical industries will further solidify our leadership in API manufacturing—this is an exciting time for our organization,” said chief executive officer Stephan Kutzer.
Dolan recently served as vice president of global operations at Johnson Matthey, a chemicals and precious metals company headquartered in London. He has 30 years of operations and management experience in the refining, automotive, fine chemical and pharmaceutical industries.
Addressing Husain’s appointment, Kutzer added, “Mr. Husain’s diverse experience in both business development and operations will allow us to continue to provide our customers with best-in-class solutions in the API manufacturing industry.”
Husain recently served as the head of business development and business team at Lonza Group Ltd., a chemicals and biotechnology company headquartered in Basel, Switzerland. He has over 10 years of in-depth experience in sales, business development, marketing and operations.
AAIPharma Services Corp., headquartered in Wilmington, N.C., is a leading global provider of pharmaceutical analytical testing, product development and manufacturing services. AAIPharma Services Corp. merged with Cambridge Major Laboratories Inc. to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services.
